Getting Data Governance for Regulatory Submissions Right Before AI Gets it Wrong with Cary Smithson
Episode
28 min
Read time
2 min
Topics
Health & Wellness, Artificial Intelligence, Software Development
AI-Generated Summary
Key Takeaways
- ✓Scope-First Governance: Avoid attempting to govern all data simultaneously. Identify the highest-pain critical data elements (CDEs) — such as product master, substance, dosage form, and manufacturing site data — within a narrow scope first. Demonstrate measurable value quickly to secure ongoing budget, then scale systematically across clinical, regulatory, quality, and manufacturing domains.
- ✓Business-Owned Stewardship Model: Assign data ownership to business domain experts, not IT. Establish a formal data governance council with named stewards per domain who hold accountability for data exchange, field changes, standards updates, and approval workflows. Tie steward compliance to performance metrics like submission cycle time and right-first-time rates to drive adoption.
- ✓AI Reliability Depends on Governed Inputs: AI models trained on nonstandard or low-quality data produce erroneous, noncompliant, or unexplainable outputs. A midsize biopharma implementing IDMP-aligned governance achieved 30–50% faster affiliate submissions, 25% fewer health authority queries, and successfully deployed AI-assisted CMC authoring — all within twelve months of launching their data governance program.
- ✓Regulatory Framework Crosswalk: Maintain a living crosswalk mapping enterprise master data to regulatory data models including RIM and eCTD, with full traceability from source systems to submission artifacts. For IDMP and SPORE, harmonize product and substance attributes across systems. For PQCMC, build CMC data models reflecting manufacturing process parameters, control strategies, and analytical methods fed directly from governed sources.
- ✓Governance as Persistent Program, Not Project: Embed data governance into existing SOPs, change control processes, system validation (SDLC), and training workflows rather than treating it as a standalone initiative. Monitor health via KPIs including data quality scores, lineage completeness, issue remediation SLA adherence, and submission right-first-time rates, with a continuous improvement loop managed by the governance council.
What It Covers
Cary Smithson of Leap Ahead Solutions outlines how life science companies must establish structured data governance frameworks to meet regulatory submission standards like IDMP, PQCMC, and HL7 FHIR, while building the data foundation required for safe, compliant AI adoption across R&D, regulatory, and quality functions.
Key Questions Answered
- •Scope-First Governance: Avoid attempting to govern all data simultaneously. Identify the highest-pain critical data elements (CDEs) — such as product master, substance, dosage form, and manufacturing site data — within a narrow scope first. Demonstrate measurable value quickly to secure ongoing budget, then scale systematically across clinical, regulatory, quality, and manufacturing domains.
- •Business-Owned Stewardship Model: Assign data ownership to business domain experts, not IT. Establish a formal data governance council with named stewards per domain who hold accountability for data exchange, field changes, standards updates, and approval workflows. Tie steward compliance to performance metrics like submission cycle time and right-first-time rates to drive adoption.
- •AI Reliability Depends on Governed Inputs: AI models trained on nonstandard or low-quality data produce erroneous, noncompliant, or unexplainable outputs. A midsize biopharma implementing IDMP-aligned governance achieved 30–50% faster affiliate submissions, 25% fewer health authority queries, and successfully deployed AI-assisted CMC authoring — all within twelve months of launching their data governance program.
- •Regulatory Framework Crosswalk: Maintain a living crosswalk mapping enterprise master data to regulatory data models including RIM and eCTD, with full traceability from source systems to submission artifacts. For IDMP and SPORE, harmonize product and substance attributes across systems. For PQCMC, build CMC data models reflecting manufacturing process parameters, control strategies, and analytical methods fed directly from governed sources.
- •Governance as Persistent Program, Not Project: Embed data governance into existing SOPs, change control processes, system validation (SDLC), and training workflows rather than treating it as a standalone initiative. Monitor health via KPIs including data quality scores, lineage completeness, issue remediation SLA adherence, and submission right-first-time rates, with a continuous improvement loop managed by the governance council.
Notable Moment
Smithson highlights a counterintuitive risk with AI: failures may go entirely undetected. When AI models ingest poor-quality or nonstandard data, they can generate misleading results that appear valid, making invisible errors potentially more dangerous than obvious ones in regulated submission environments.
You just read a 3-minute summary of a 25-minute episode.
Get The Life Science Rundown summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from The Life Science Rundown
TerSera's VP of Quality on the Audit Risk Hiding Inside Your Own Procedures
May 18 · 30 min
The Long Run with Luke Timmerman
Ep196: Otello Stampacchia on Europe's Biotech Crisis
Mar 17
More from The Life Science Rundown
What Auditors Are Actually Looking For — and the Psychology Behind How They Find It
Apr 28 · 19 min
Beyond Biotech
M Ventures: pharma CVC and biotech innovation in 2026
Jan 9
More from The Life Science Rundown
We summarize every new episode. Want them in your inbox?
TerSera's VP of Quality on the Audit Risk Hiding Inside Your Own Procedures
What Auditors Are Actually Looking For — and the Psychology Behind How They Find It
Why Kidney Disease Innovation Is a Tale of Two Cities — and What It Would Take to Change That
Syncing Global Regulatory Filings Across FDA, EMA, and PMDA with AJ Acker
Navigating Regulatory Leadership Across Large and Small Life Science with Tammy Sarnelli
Similar Episodes
Related episodes from other podcasts
The Long Run with Luke Timmerman
Mar 17
Ep196: Otello Stampacchia on Europe's Biotech Crisis
Beyond Biotech
Jan 9
M Ventures: pharma CVC and biotech innovation in 2026
The Daily (NYT)
Jun 14
Do Aliens Exist? Steven Spielberg Believes They Do
Huberman Lab
Jun 11
Essentials: Sleep Toolkit for Optimizing Sleep & Sleep-Wake Timing
Modern Wisdom
Jun 11
Harvard Professor: Why Nothing Feels Real Anymore - Arthur Brooks - #1109
Explore Related Topics
This podcast is featured in Best Science Podcasts (2026) — ranked and reviewed with AI summaries.
Read this week's Health & Longevity Podcast Insights — cross-podcast analysis updated weekly.
You're clearly into The Life Science Rundown.
Every Monday, we deliver AI summaries of the latest episodes from The Life Science Rundown and 192+ other podcasts. Free for up to 3 shows.
Start My Monday DigestNo credit card · Unsubscribe anytime